The nitric oxide theory of aging revisited

Annals of the New York Academy of Sciences

Volumn 1057, Issue , 2005, Pages 64-84

  McCann, Samuel M ^a,c   Mastronardi, C ^b   De Laurentiis, A ^a   Rettori, V ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE   (Argentina)

Author keywords

Bacterial lipopolysaccharide; Brain; Coronary heart disease; Cyclic GMP; Cyclooxygenase; Cytokines; Degenerative diseases; Hypothalamus; Infection; Inflammation; Nitric oxide synthase; Pineal gland; Pituitary gland; Stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; CORTICOSTERONE; CYCLIC GMP; CYTOKINE; GONADORELIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LEPTIN; MITOCHONDRIAL ENZYME; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; BRAIN; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORTICOSTERONE RELEASE; CYTOKINE PRODUCTION; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; IMMUNE SYSTEM; INFLAMMATION; ISCHEMIC HEART DISEASE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PARKINSONISM; PINEAL BODY; STRESS;

BACTERIA (MICROORGANISMS);

EID: 32244435930     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1356.064     Document Type: Conference Paper

References (69)

1. KIRKWOOD, T.B.L. & A. KOWALD. 1997. Network theory of aging. Exp. Gerontol. 32: 395-399.
2. MCCANN, S.M., J. LICINIO, M.L. WONG, et al. 1997. The nitric oxide hypothesis of brain aging. Exp. Gerontol. 32: 431-440.
3. WONG, M.L., V. RETTORI, A. AL-SHEKHELEE, et al. 1996. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 2: 581-584.
4. MCCANN, S.M. & V. RETTORI. 1996. The role of nitric oxide in reproduction. Proc. Soc. Exp. Biol. Med. 211: 7-15.
5. MCDONALD, L.J. & F. MURAD. 1996. Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med. 211: 1-6.
6. BORNSTEIN, S.R., R.R. SCHUMANN, V. RETTORI. et al. 2004. Toll-like Receptor 2 and toll-like receptor 4 expression in human adrenals. Horm. Metab. Res. 36: 470-473.
7. BREDT, D.S., P.M. HWANG, S.H. SNYDER. 1990. Localization of nitric oxide synthase I indicating a neural role for nitric oxide. Nature 347: 768-770.
8. GIUVILI, C., J.J. PODEROSO & A. BOVERIS. 1998. Production of nitric oxide by mitochondria. J. Biol. Chem. 273: 11038-11043.
9. NAVARRO, A., M.J. SÁNCHEZ DEL PINO, C. GÓMEZ, et al. 2002. Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282: 985-992.
10. PALMER, R.M.J., A.G. FERRIGE & S. MONCADA. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
11. GARTHWAITE, J., S.L. CHARLES & R. CHESS-WILLIAMS. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388.
12. KARANTH, S., K. LYSON & S.M. MCCANN. 1993. Role of nitric oxide in interleukin 2-induced corticotropin releasing factor release from incubated hypothalami. Proc. Natl. Acad. Sci. USA 90: 3383-3387.
13. RETTORI, V., M. GIMENO, K. LYSON & S.M. MCCANN. 1992. Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus. Proc. Natl. Acad. Sci. USA 89: 11543-11546.
14. CANTEROS, G., V. RETTORI, A. FRANCHI, et al. 1995. Ethanol inhibits luteinizing hormone releasing hormone (LHRH) secretion by blocking the response of LHRH neuronal terminals to nitric oxide. Proc. Natl. Acad. Sci. USA 92: 3416-3420.
15. HINEY, J.K., W.H. SOWER, W.H. YU, et al. 2002. Gonadotropin releasing hormone neurons in the preoptic-hypothalamic region of the rat contain lamprey gonadotropin releasing hormone III, mammalian luteinizing hormone-releasing hormone, or both peptides. Proc. Natl. Acad. Sci. USA 99: 2386-2391.
16. MCCANN, S.M., S. KARANTH, C.A. MASTRONARDI, et al. 2002. Hypothalamic control of gonadotrophin secretion. Prog. Brain Res. 141: 153-166.
17. KAMAT, A., W.H. YU, V. RETTORI & S.M. MCCANN. 1995. Glutamic acid stimulated luteinizing-hormone releasing hormone release is mediated by alpha adrenergic stimulation of nitric oxide release. Brain Res. Bull. 37: 233-235.
18. RETTORI, V., N. BELOVA, W.L. DEES, et al. 1993. Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro. Proc. Natl. Acad. Sci. USA 90: 10130-10134.
19. MANI, S.K., J.M.C. ALLEN, V. RETTORI, et al. 1994. Nitric oxide mediates sexual behavior in female rats by stimulating LHRH release. Proc. Natl. Acad. Sci. USA 91: 6468-6472.
20. MCCANN, S.M., C. MASTRONARDI, A. WALCZEWSKA, et al. 2003. The role of NO in the control of LHRH release that mediates gonadotrophin release and sexual behavior. Curr. Pharmacol. Des. 9: 381-390.
21. RETTORI, V., G. CANTEROS, R. REYNOSO, et al. 1991. Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamic explants by releasing nitric oxide. Proc. Natl. Acad. Sci. USA 94: 2741-2744.
22. SEILICOVICH, A., B.H. DUVILANSKI, D. PISERA, et al. 1995. Nitric oxide inhibits hypothalamic luteinizing hormone-releasing hormone release by releasing γ-aminobutyric acid. Proc. Natl. Acad. Sci. USA 92: 3421-3424.
23. SEILICOVICH, A., M. LASAGA, M. BEFUMO, et al. 1995. Nitric oxide inhibits the release of norepinephrine and dopamine from the medial basal hypothalamus of the rat. Proc. Natl. Acad. Sci. USA 92: 11299-11302.
24. RETTORI, V., N. BELOVA, W.H. YU, et al. 1994. Role of nitric oxide in control of growth hormone release in the rat. Neuroimmunomodulation 1: 195-200.
25. AGUILA, M.C. 1994. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc. Natl. Acad. Sci. USA 91: 782-786.
26. RETTORI, V., N. BELOVA, M. GIMENO & S.M. MCCANN. 1994. Inhibition of nitric oxide synthase in the hypothalamus blocks the increase in plasma prolactin induced by intraventricular injection of interleukin-1a in the rat. Neuroimmunomodulation 1: 116-120.
27. DUVILANSKI, B.H., C. ZAMBRUNO, A. SEILICOVICH, et al. 1995. Role of nitric oxide in control of prolactin release by the adenohypophysis. Proc. Natl. Acad. Sci. USA 92: 170-174.
28. SCHULTZ, C., H. BRAAK & E. BRAAK. 1997. A sex difference in neurodegeneration of the human hypothalamus. Abstract presented at the 3rd International Symposium on Neurobiology and Neuroendocrinology of Aging. Bregenz, Austria.
29. SAGAR, S.M. & D.M. FERREIRO. 1987. NADPH diaphorase activity in the posterior pituitary: relation to neuronal function. Brain Res. 400: 348-352.
30. CALKA, J. & C.H. BLOCK. 1993. Relationship of vasopressin with NADPH-diaphorase in the hypothalamo-neurohypophyseal system. Brain Res. Bull. 32: 207-210.
31. MIYAGAWA, A., H. OKAMURA & Y. IBATA. 1994. Coexistence of oxytocin and NADPH-diaphorase in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus. Neurosci. Lett. 171: 13-16.
32. KADEKARO, M., M.L. TERRELL, H. LIU, et al. 1998. Effects of L-NAME on cerebral, vasopressin, oxytocin, and blood pressure responses in hemorrhaged rats. Am. J. Physiol. 274: 1070-1077.
33. LIU, Q.S., Y. JIA & G. JU. 1997. Nitric oxide inhibits neuronal activity in the supraoptic nucleus of the rat hypothalamic slices. Brain Res. Bull. 43: 121-125.
34. NUSSDORFER, G.G. & L.K. MALENDOWICZ. 1998. Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19: 949-968.
35. EUTAMENE, H., V. THEODOROU, J. FIORAMONTI & L. BUENO. 1995. Implication of NK1 and NK2 receptors in rat colonic hypersecretion induced by interleukin 1 beta: role of nitric oxide. Gastroenterology 109: 483-489.
36. FIGGINI, M., C. EMANUELI, C. BERTRAND, et al. 1996. Evidence that tachykinins relax the guinea pig trachea via nitric oxide release and by stimulation of a peptide-insensitive NK1 receptor. Br. J. Pharmacol. 117: 1270-1276.
37. PORTBURY, A.L., J.B. FURNESS, B.R. SOUTHWELL, et al. 1996. Distribution of neurokinin-2 receptors in the guinea pig gastrointestinal tract. Cell Tissue Res. 286: 281-292.
38. DE LAURENTIIS, A., D. PISERA, B. DUVILANSKI, et al. 2000. Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase. Brain Res. Bull. 53: 325-330.
39. EISTETTER, H.R., A. MILLS & S.J. ARKINSTALL. 1993. Signal transduction mechanisms of recombinant bovine neurokinin-2 receptor stably expressed in baby hamster kidney cells. J. Cell. Biochem. 52: 84-91.
40. + channels. J. Physiol. Lond. 520: 165-176.
41. THEODOSIS, D.T. & B. MACVICAR. 1996. Neurone-glia interactions in the hypothalamus and pituitary. Trends Neurosci. 19: 363-367.
42. VIZI, E.S. & B. SPERLAGH. 1999. Separation of carrier mediated and vesicular release of GABA from rat brain slices. Neurochem. Int. 34: 407-413.
43. CROWLEY W. & W. ARMSTRONG. 1992. Neurochemical regulation of oxytocin secretion in lactation. Endocr. Rev. 13: 33-65.
44. SCHNEGGENBURGER, R. & A. KONNERTH. 1992. GABA-mediated synaptic transmission in neuroendocrine cells: a patch-clamp study in a pituitary slice preparation. Pflugers Arch. 421: 346-373.
45. SLADEK, C. & W. ARMSTRONG. 1987. Gamma-aminobutyric acid antagonists stimulate vasopressin release from organ cultured hypothalamo-neurohypophyseal explants. Endocrinology 120: 1576-1580.
46. PISERA, D., A. DE LAURENTIIS, B. DUVILANSKI, et al. 1996. Neurokinin A affects the tubero-hypophyseal GABAergic system. Neuroreport 7: 2236-2240.
47. YU, W.H., M. KIMURA, A. WALCZEWSKA, et al. 1998. Adenosine acts by A1 receptors to stimulate release of prolactin from anterior-pituitaries in vitro. Proc. Natl. Acad. Sci. USA 95: 7795-7798.
48. YU, W.H., A. WALCZEWSKA, S. KARANTH & S.M. MCCANN. 1997. Nitric oxide mediates leptin-induced luteinizing hormone releasing hormone (LHRH) and LHRH and leptin-induced LH release from the pituitary gland. Endocrinology 138: 5055-5058.
49. RETTORI, V., W.L. DEES, J.K. HINEY, et al. 1994. An interleukin-1a-like neuronal system in the preoptic-hypothalamic region and its induction by bacterial lipopolysaccharide in concentrations which alter pituitary hormone release. Neuroimmunomodulation 1: 251-258.
50. BANKS, W.A., A.J. KASTIN & R.D. BROADWELL. 1995. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2: 241-248.
51. PIERPAOLI, W., D. BULIAN, A. DALL'ARA, et al. 1997. Circadian melatonin and young-to-old pineal grafting postpone aging and maintain juvenile conditions of reproductive functions in mice and rats. Exp. Gerontol. 32: 587-602.
52. KARANTH, S., W.H. YU, C.A. MASTRONARDI & S.M. MCCANN. 2004. Inhibition of stimulated ascorbic acid and luteinizing hormone-releasing hormone by nitric oxide synthase or guanylyl cyclase inhibitors. Exp. Biol. Med. 229: 72-79.
53. MASTRONARDI, C.A., W.H. YU & S.M. MCCANN. 2001. Comparisons of the effects of anesthesia and stress on release of tumor necrosis factor-alpha, leptin, and nitric oxide in adult male rats. Exp. Biol. Med. 226: 296-300.
54. MASTRONARDI, C.A., W.H. YU, S.M. MCCANN. 2001. Lipopolysaccharide-induced tumor necrosis factor-alpha release is controlled by the central nervous system. Neuroimmunomodulation 9: 148-156.
55. KISHIMOTO, J., T. TSUCHIYA, P.C. EMSON & Y. NAKAYAMA. 1996. Immobilization-induced stress activates neuronal nitric oxide synthase (nNOS) mRNA and protein in hypothalamic-pituitary-adrenal axis in rats. Brain Res. 720: 159-171.
56. PRZEDBORSKI S., V. JACKSON-LEWIS, R. YOKOYAMA, et al. 1996. Role of neuronal NO in 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP)-induced dopaminergic toxicity. Proc. Natl. Acad. Sci. USA 93: 4565-4571.
57. KNOLL, J. 1997. Sexual performance and longevity. Exp. Gerontol. 32: 539-552.
58. GRIFFIN, S. 1998. Neuroimmunomodulation Symposium. Am. Assoc. Immunol. Meet. San Francisco. April, 1998.
59. XIAO-JIANG, L., A.H. SHARP, L. SHI-HUA, et al. 1996. Huntington- associated protein (HAPI): discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93: 4839-4844.
60. WONG, M.L., F. O'KIRWAN, N. KHAN, et al. 2003. Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis. Proc. Natl. Acad. Sci. USA 100: 14241-14246.
61. DANESH, J., R. COLLINS & R. PETO. 1997. Chronic infections and coronary heart disease: is there a link? Lancet 350: 430-436.
62. FABRICANT, C.G., J. FABRICANT, M.M. LITRENTA & C.R. MINICK. 1978. Virus-induced atherosclerosis. J. Exp. Med. 148: 335-340.
63. GURFINKEL, E., G. BOZOVICH, A. DAROCA, et al. 1997. For the ROXIS Study Group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350: 404-407.
64. GUPTA, S., E.W. LEATHAM, D. CARRINGTON, et al. 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in the male survivors of myocardial infarction. Circulation 96: 404-407.
65. AMIN, A.R., M.G. ATTUR, G.D. THAKKER, et al. 1996. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. USA 93: 14014-14019.
66. MASTRONARDI, C.A., W.H. YU, V.K. SRIVASTAVA, et al. 2001. Lipopolysaccharide-induced leptin release is neurally controlled. Proc. Natl. Acad. Sci. USA 98: 14720-14725.
67. MASTRONARDI, C.A., W.H. YU & S.M. MCCANN. 2002. Resting and circadian release of nitric oxide is controlled by leptin in male rats. Proc. Natl. Acad. Sci. USA 99: 5721-5726.
68. MOHN, C., J. FERNANDEZ SOLARI, A. DE LAURENTIIS, et al. 2005. The rapid release of corticosterone from the adrenal induced by ACTH is mediated by NO acting by PGE2. Proc. Natl. Acad. Sci. USA 102: 6213-6218.
69. SCHRINER, S.E., N.J. LINFORD, G.M. MARTIN, et al. 2005. Extension of murine lifespan by overexpression of catalase targeted to mitochondria. Science 308: 1909-1911.